SUNPHARMA Sun Pharmaceuticals Industries Ltd Legal Disputes Announcement 2024 - Regulatory Penalty Sun Pharmaceuticals subsidiary received a regulatory order imposing a penalty of ₹7,08,422 for excess availment of input tax credit, but it is expected to have no material impact on the companys operations or finances..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sun Pharmaceuticals Industries Ltd